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Activity-regulated cytoskeleton-associated protein (Arc) protein is implicated as a
master regulator of long-term forms of synaptic plasticity and memory formation,
but the mechanisms controlling Arc protein function are little known. Post-translation
modification by small ubiquitin-like modifier (SUMO) proteins has emerged as a major
mechanism for regulating protein-protein interactions and function. We first show in
cell lines that ectopically expressed Arc undergoes mono-SUMOylation. The covalent
addition of a single SUMO1 protein was confirmed by in vitro SUMOylation of
immunoprecipitated Arc. To explore regulation of endogenous Arc during synaptic
plasticity, we induced long-term potentiation (LTP) in the dentate gyrus of live
anesthetized rats. Using coimmunoprecipitation of native proteins, we show that
Arc synthesized during the maintenance phase of LTP undergoes dynamic mono-
SUMO1-ylation. Levels of unmodified Arc increase in multiple subcellular fractions
(cytosol, membrane, nuclear and cytoskeletal), whereas enhanced Arc SUMOylation
was specific to the synaptoneurosomal and the cytoskeletal fractions. Dentate gyrus
LTP consolidation requires a period of sustained Arc synthesis driven by brain-derived
neurotrophic factor (BDNF) signaling. Local infusion of the BDNF scavenger, TrkB-Fc,
during LTP maintenance resulted in rapid reversion of LTP, inhibition of Arc synthesis
and loss of enhanced Arc SUMO1ylation. Furthermore, coimmunoprecipitation analysis
showed that SUMO1-ylated Arc forms a complex with the F-actin-binding protein
drebrin A, a major regulator of cytoskeletal dynamics in dendritic spines. Although Arc
also interacted with dynamin 2, calcium/calmodulindependent protein kinase II–beta
(CaMKIIβ), and postsynaptic density protein-95 (PSD-95), these complexes lacked
SUMOylated Arc. The results support a model in which newly synthesized Arc is
SUMOylated and targeted for actin cytoskeletal regulation during in vivo LTP.
Keywords: actin cytoskeleton, brain-derived neurotrophic factor (BDNF), dentate gyrus, hippocampus, immediate
early protein, long-term potentiation (LTP), small ubiquitin-like modifier (SUMO), synaptic plasticity
Abbreviations: AMPA, α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; Arc, activity-regulated
cytoskeleton-associated protein; BDNF, brain-derived neurotrophic factor; HFS, high-frequency stimulation;
LTP, long-term potentiation; PSD-95, postsynaptic density protein-95; SUMO, Small ubiquitin-like modifier.
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INTRODUCTION
Activity-regulated cytoskeleton-associated protein (Arc) has
been identified as an indispensable component of multiple forms
of protein synthesis-dependent plasticity, including long-term
potentiation (LTP), long-term depression (LTD) and related
homeostatic synaptic scaling (Bramham et al., 2010; Korb
and Finkbeiner, 2011; Shepherd and Bear, 2011). Behaviorally,
Arc synthesis is critical to long-term memory formation and
processes of extinction and reconsolidation, as well as postnatal
development of the visual cortex (Guzowski et al., 2000; Plath
et al., 2006; McCurry et al., 2010; Trent et al., 2015). Arc is rapidly
transcribed in response to glutamatergic synaptic signaling and
transported to dendrites for local translation and synaptic action
of the protein; Arc is also synthesized in the cell body and acts
in the nucleus (Bloomer et al., 2007; Bramham et al., 2010; Korb
et al., 2013; Steward et al., 2015).
In LTD and homeostatic scaling, Arc forms a complex
with dynamin 2 and endophilin 3 to facilitate endocytosis
of AMPA-type glutamate receptors (Chowdhury et al., 2006;
Shepherd et al., 2006; Peebles et al., 2010; DaSilva et al., 2016).
During LTP consolidation, newly synthesized Arc promotes
stable increases in filamentous (F-) actin implicated in the
structural enlargement of dendritic spines (Messaoudi et al.,
2007). In inverse synaptic tagging, Arc is targeted to less
active synapses through binding to inactive calcium/calmodulin-
dependent protein kinase II–beta (CaMKIIβ; Okuno et al., 2012).
In the nucleus, Arc interacts with multiple proteins to modulate
transcription and chromatin state (Bloomer et al., 2007; Korb
et al., 2013; Wee et al., 2014; Oey et al., 2015). Structurally, Arc
is a flexible protein comprised of two major domains flanking
a central, mostly disordered hinge region (Myrum et al., 2015;
Zhang et al., 2015).
The ability of Arc to interact with diverse protein partners
may explain its functional versatility. However, the mechanisms
that regulate Arc protein localization and protein-protein
interactions are little known. The covalent attachment of
small ubiquitin-like modifier (SUMO) has emerged as a
major mechanism for regulating protein localization, activity,
and function and many of these effects are mediated via
SUMO-directed protein-protein interactions (Gareau and Lima,
2010; Flotho and Melchior, 2013; Hay, 2013). Four SUMO
paralogs (SUMO-1-4) have been identified in mammals,
though only SUMO1-3 are ubiquitously expressed. SUMO2 and
SUMO3 differ by only 3 amino acids and are collectively referred
to as SUMO2/3. In neurons, SUMOylation dependent regulation
of numerous proteins including regulators of neurotransmitter
release and postsynaptic glutamatergic signaling has been
demonstrated (Martin et al., 2007; Kantamneni et al., 2011;
Henley et al., 2014; Craig et al., 2015; Schorova andMartin, 2016).
Neuronal activity regulates the distribution of the SUMOylation
machinery and SUMOylation is required for LTP induction and
hippocampal-dependent memory formation (Loriol et al., 2013;
Lee et al., 2014).
Arc has recently been identified as an in vitro SUMO
substrate (Bramham et al., 2010; Craig et al., 2012).
However, SUMOylation of endogenous Arc in the context
of synaptic plasticity has not been explored. Here, we
show that newly synthesized Arc is rapidly SUMOylated
during LTP consolidation in the dentate gyrus of live rats.
SUMO1 conjugated Arc is concentrated to the synaptic,
cytoskeletal fraction where it forms a complex with drebrin A,
a regulator of F-actin stability in dendritic spines. Although
Arc also interacts with dynamin 2, CaMKIIβ and postsynaptic
density protein-95 (PSD-95), these complexes lack SUMOylated
Arc. The results support a model in which SUMO1-ylation
targets Arc for regulation of actin cytoskeletal dynamics in LTP.
MATERIALS AND METHODS
Materials
Antibodies: Arc C7 mouse monoclonal (1:200, sc-17839),
Arc H300 rabbit polyclonal (1:200, sc-15325), Cofilin (1:500,
sc-32158), Drebrin A (1:200, #sc-374269), Dynamin 2 (1:1000,
sc-6400), GAPDH (1:5000, sc-32233), Histone 1 (1:500, sc-
10806), rabbit polyclonal SUMO1 (1:1000, sc-9060), mouse
monoclonal SUMO1 (1:1000, sc-5308), SUMO2/3 (1:1000,
sc-32873), normal mouse IgG and rabbit IgG were from
Santa Cruz Biotechnology. Arc Synaptic Systems (1:1000,
156003) β-actin (1:5000 Sigma, #F3022), Cofilin (1:500, Cell
signaling #5175), Drebrin A (1:500, Cell signaling #12243S),
CaMKIIα (1:500, Chemicon, #MAB8699), CaMKIIβ (Invitrogen
#139800), His6-tag (1:1000, Millipore #5531), PSD-95 (1:1000,
Thermo scientific #MA1-045), Vimentin (1:1000, Sigma
#V5225).
Recombinant TrkB-Fc (stock 100 µg/ml, #688-TK) and
control human IgG-Fc (100 µg/ml, #110-HG) were obtained
from R&D Systems and diluted in phosphate-buffered saline
(PBS) containing 0.1% bovine serum albumin. The cDNA
encoding Arc was a gift from Dr. Joseph Dynes, University of
California, Irvine, USA. Expression constructs for His6-tagged
SUMO1, 2 and 3 were kindly provided by Dr. Ronald Hay,
University of Dundee, UK.
Generation of Arc Expression Constructs
Arc cDNA (amino acid residues 1-396) was cloned between
the HindIII and BamHI sites in pCDNA3.1 (+). Restriction
and modification enzymes and other molecular biology related
chemicals were from New England Biolabs or Fermentas. The
sequences of the Arc constructs were confirmed by DNA
sequencing by the dideoxy chain termination method in an
automated DNA sequencer (ABI Prism 310).
Expression of Arc in HT-1080 Cells
HT-1080 (Human fibrosarcoma) cells were cultured as a
monolayer in DMEM containing 10% FBS and antibiotics
(penicillin 100 units/ml, streptomycin 100 µg/ml, fungizone
2.5 µg/ml) at 37◦C in a humid atmosphere having 5% CO2. For
transient transfection, HT-1080 cells were seeded on 35 mm or
100 mm sterile petri dishes. After 24 h, the cells were transfected
with plasmid constructs using Lipofectamine 2000 according to
the manufacture’s protocol (0.750 µg or 5 µg of plasmid DNA
per 35 mm or 100 mm petriplate, respectively). Transfection
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grade plasmids were prepared using plasmid Midi kit from
Qiagen.
Nickel Affinity Chromatograhpy
Extract from HT-1080 cells coexpressing Arc and His6-tagged
SUMO1, 2 or 3 was subjected to nickel affinity chromatography
and subsequent immunoblotting analysis was performed
using Arc antibody. Ni+-nitrilotriacetate (NTA) agarose beads
from Qiagen (50 µg/purification) were washed three times
using dilution/wash buffer containing NaH2PO4 (50 mM),
NaCl (300 mM) and imidazole (10 mM). Washed beads
were incubated overnight at 4◦C with approximately 300 µg
lysate from transfected cells prepared in RIPA lysis buffer
containing 1× protease inhibitor, diluted 10 times with the
dilution/wash buffer. The incubated beads were washed
three times using dilution/wash buffer and centrifuged
at 500× g. Subsequently the bound proteins were eluted
in 30 µl elution buffer containing NaH2PO4 (50 mM),
NaCl (300 mM) and imidazole (250 mM). The samples
were denatured, resolved by SDS-PAGE, and subjected to
immunoblotting.
In Vitro SUMOylation of
Immunoprecipitated Arc
HT-1080 cells seeded in 100 mm culture plates were transfected
with 5 µg of plasmid, using Lipofectamine 2000. After 24 h from
the start of lipofection the cells were lysed either in RIPA lysis
buffer (Santacruz sc-24948A) containing 1× protease inhibitor
cocktail and 10 mM N-ethylmaleimide (NEM) or a modified
RIPA buffer containing 20 mM Tris-HCl (pH 7.4), 150 mM
NaCl, 0.5% Triton, 5% glycerol, 10 mM NEM and 1× protease
inhibitor cocktail. The homogenate was then centrifuged at
20,000× g for 5 min at 4◦C, and the supernatant was
collected for subsequent immunoprecipitation. A preliminary
Arc-immunoblot was carried out with equal amount of total
proteins, to quantitate the amount of overexpressed protein
present in the cell lysate. Immunoprecipitation was performed
using anti-Arc antibody (C7 Santa Cruz) and the precipitate was
used as the substrate for the in vitro SUMOylation assay carried
out with E1 activating and E2 conjugating enzymes according
to the manufacturer’s instructions (SUMOlink SUMO1, Active
Motif).
Animals
In vivo electrophysiological experiments were carried out on
105 adult (60–80 day old) male rats of the Sprague-Dawley
outbred strain (Taconic Europe, Ejby, Denmark), weighing
250–350 g. Dentate gyrus tissue was also obtained from 10 naïve,
anesthetized rats. Rats had free access to food and water and
were on a 12-h light/dark cycle. This research is approved by
Norwegian National Research Ethics Committee in compliance
with EU Directive 2010/63/EU, ARRIVE guidelines. Persons
involved in the animal experiments have approved Federation of




The electrophysiological methods have been detailed elsewhere
(Panja et al., 2009). Briefly, rats were anesthetized with urethane
(1.5 g/kg) and electrodes were stereotaxically positioned for
unilateral stimulation of the medial perforant path (7.9 posterior
to bregma, 4.2 lateral and depth 2.5) and recording of evoked
field potentials in the dentate gyrus (3.7 posterior, 2.2 lateral,
depth 2.8). Drugs were infused above via a glass micropipette
attached to an infusion pump (infusion rate was 0.06 µl/min)
connected via a polyethylene (PE50) tube to a 5 µl Hamilton
syringe (Reno, NV). The recording electrode and infusion pipette
were clamped together on a micromanipulator with a vertical
tip separation of 700 µm. The tip of the infusion cannula was
located in deep stratum lacunosum-moleculare of field CA1,
approximately 300 µm dorsal to the synaptic zone of medial
perforant path-granule synapses in the upper blade of the dorsal
dentate gyrus. Test pulses were applied at 0.033 Hz throughout
the experiment except during the period of HFS. Responses
were allowed to stabilize and 20 min of baseline recordings
were obtained. HFS was given in three sessions with 5 min
between them. Each session consisted of four, 400 Hz stimulus
trains (8 pulses/ train) and the interval between trains was 10 s.
Total HFS duration was 10.5 min and the total pulse number
was 96.
Tissue Dissection, Homogenization and
Immuonprecipitation
At the end of electrophysiological recording, rats were
decapitated and the dentate gyri were rapidly dissected
on ice and homogenized in buffer containing 20 mM
Hepes pH 7.4, 137 mM NaCl, 1 mM EDTA, 1 mM NaF,
1 mM sodium orthovanadate, 0.5% NP-40, 1 mM DTT,
20 mM NEM and protease inhibitor cocktail (Roche,
# 11836170001). Homogenization was performed manually
with 10–12 gentle strokes in a tissue grinder with a clearance
of 0.1–0.15 mm (Thomas Scientific, Swedesboro, NJ, USA).
Protein concentration was measured using BCA protein
assay (Pierce, # 23227). Homogenates were stored at −80◦C
until use.
Two micrograms of antibody was incubated for 1 h at room
temperature with 20 µl of washed protein G-agarose beads or
protein A/G mix magnetic beads (Cat. No. LSKMAGAG02,
Millipore) for each immunoprecipitation. Two-hundred to two-
hundred and fifty micrograms lysate (from dentate gyrus,
synaptoneurosomes, or the cytoskeletal fraction) was incubated
with antibody-bound beads at 4◦C for 2 h or overnight.
Immunoprecipitates were washed four times with washing buffer
(20 mM Hepes pH 7.4, 137 mM NaCl, 1 mM EDTA, 20 mM
NEM) and proteins were eluted from the beads by boiling in
reducing sample buffer. In the analysis of NEM sensitivity, NEM
was omitted from the lysis and immunprecipitation buffers.
In Vitro SENP1 Treatment
To assay the hydrolysis activity of SENP1 in vitro,
immunoprecipitates were washed three times with lysis
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buffer and beads were divided equally. The washed beads were
incubated in 30 µl reaction buffer (150 mM NaCl, 50 mM
Tris/HCl and 5 mM dithiothreitol) containing 300 nM of the
purified catalytic domain of SENP1 (E-700-050, R&D system
or UW9760, Enzo life sciences) for 2 h at 37◦C. SENP1 was
omitted from control samples. Every 15 min, the Eppendorf
tube was hand-shaken to facilitate the reaction. After incubation,
the reactions were terminated by adding 2× sample loading
buffer and subjected to SDS/PAGE analysis and immunoblotting
subsequently. NEM was included in the lysis buffer prior to
immunoprecipitation.
SDS–PAGE and Immunoblotting
Samples were boiled in sample buffer (Bio-Rad) and resolved
via 10% or 8% SDS-PAGE mini gels. Proteins were transferred
to nitrocellulose membranes (Amersham Biosciences), blocked
with 5% non-fat dry milk, probed with horseradish peroxidase-
conjugated anti-rabbit or anti-mouse secondary antibodies
(1:10,000, Calbiochem) and developed using chemiluminescence
reagents (ECL, Pierce). For coimmunoprecipitation analysis of
SUMOylated Arc, antibody-treated blots were stripped with
100 mM 2-mercaptoethanol, 2% SDS and 62.5 mM Tris-
HCl, pH 6.7 at 50◦C for 30 min, washed, blocked and
reprobed with antibody recognizing a different protein (Arc or
SUMO).
Synaptoneurosomal Preparation
At the end of electrophysiological recording, rats were
decapitated and the dentate gyri (treated and control)
were rapidly dissected on ice and homogenized in 5 ml
of homogenization buffer (0.32 M sucrose, 1 mM EDTA,
1 mg/ml BSA and 5 mM HEPES pH 7.4) and centrifuged
at 3000× g for 10 min at 4◦C. The resulting supernatant
was centrifuged at 14,000 rpm for 12 min at 4◦C and the
pellet resuspended in 550 µl Krebs–Ringer buffer (140 mM
NaCl, 5 mM KCl, 5 mM glucose, 1 mM EDTA and 10 mM
HEPES pH 7.4). To this, 450 µl of Percoll (45% v/v) was
added and mixed, and a synaptoneurosome-enriched top
layer was collected after centrifugation at 14,000 rpm for
2 min at 4◦C. The fraction was washed and resuspended in
400 µl HEPES-Krebs solution (140 mM NaCl, 3 mM KCl,
10 mM glucose, 2 mM MgSO4, 2 mM CaCl2 and 10 mM
HEPES pH 7.4) equilibrated at 37◦C for 10 min. Isolated
synaptoneurosomes were lysed in 20 mM Tris-HCl (pH
7.4), 150 mM NaCl, 0.5% Triton, 5% glycerol, 10 mM NEM
and 1× protease inhibitor cocktail and used for biochemical
analysis.
Subcellular Fractionation
Rat dentate gyrus tissue was excised, weighed and rinsed in
PBS (pH 7.4). A Subcellular Protein Fractionation Kit for
Tissues (Thermo Scientific # 87790) was used to separate
cytoplasmic, membrane, nuclear soluble, chromatin-bound
nuclear and cytoskeletal protein extracts, according to the
manufacturer’s instructions. The tissue was first homogenized in
the Cytoplasmic Extraction Buffer (CEB) using a tissue grinder.
The homogenate was transferred to a Thermo Scientific Pierce
Tissue Strainer in a 15 ml conical tube and centrifuged for
5 min at 500× g. The strainer with debris was discarded,
and the supernatant (cytoplasmic extract) was recovered. The
remaining pellet was resuspended in Membrane Extraction
Buffer (MEB) and incubated at 4◦C for 10 min with gentle
mixing. The membrane extract was recovered by centrifugation
at 3000× g for 5 min. The pellet was then resuspended
in Nuclear Extraction Buffer (NEB) and incubated at 4◦C
for 30 min with gentle mixing. The soluble nuclear extract
was separated by centrifugation at 5000× g for 5 min.
NEB containing micrococcal nuclease was added to the pellet
and incubated at 37◦C for 15 min with gentle mixing.
Chromatin-bound nuclear proteins were released and recovered
by centrifugation of 16,000× g for 5 min. The remaining
pellet was resuspended in Pellet Extraction Buffer (PEB) and
incubated at room temperature for 10 min. The cytoskeletal
extract was recovered by centrifugation at 16,000× g for
5 min.
Densitometry and Statistical Analylsis
Immunoblots were scanned using Gel DOC EQ (BIO RAD)
and band intensities were quantified using analytical software
(Quantity one 1D analysis software, BIORAD, Hercules,
CA, USA).
Densitometric values from the treated dentate gyrus (+)
were expressed as fold change relative to contralateral control
dentate gyrus (−). For analysis of SUMOylation state, intensity of
upper 65 kDa band (immunoreactive for Arc and SUMO1) was
normalized to 50 kDa non-modifed Arc. Pairwise comparisons
of means were evaluated with a two-tailed Student’s t-test using
Graphpad prism software. The p-value for significance was 0.05.
RESULTS
SUMOylation of Ectopically Expressed Arc
and In Vitro SUMOylation Assay
Arc was ectopically expressed in HT-1080 fibrosarcoma cells
together with His6-tagged SUMO1, SUMO2, or SUMO3.
His-associated protein complexes were purified by nickel affinity
chromatography and immunoblotted for Arc (Figure 1A).
A high molecular mass band at ∼65 kDa corresponding to
the covalent addition of single, His6-tagged SUMO to Arc
was detected for all three SUMO isoforms, with strongest
bands detected for SUMO2 and SUMO3 in this context
(Figure 1A). Furthermore, the detection of non-modified Arc
(50 kDa) in the His-SUMO pulldown indicated that Arc also
interacts non-covalently with SUMOylated proteins or free
SUMO. Covalent SUMO modification was demonstrated in
an vitro SUMOylation assay using immunoprecipitated Arc as
a substrate for a conjugation reaction mediated by E1 and
E2 enzymes. Upon addition of SUMO1 to the reaction, an
Arc immunoreactive band at 65 kDa corresponding to the
conjugation of the 11 kDa SUMO1 protein to native Arc was
detected (Figure 1B).
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FIGURE 1 | SUMOylation of ectopically expressed activity-regulated
cytoskeleton-associated protein (Arc) and in vitro SUMOylation assay.
(A) Ectopically expressed Arc is SUMOylated and forms non-covalent
complexes with small ubiquitin-like modifier 1 (SUMO1) and
SUMO2/3 moieties in HT-1080 fibrosarcoma cell lines. Extract of cells
coexpressing Arc with His6-tagged SUMO 1, 2 or 3 were subjected to nickel
affinity chromatography and immunoblotted for Arc. A high molecular mass
band at ∼65 kDa (arrow) corresponding to the covalent addition of single
His6-tagged SUMO1, SUMO2, or SUMO3 to Arc was detected. The
molecular mass of His6-SUMOylated Arc is higher than physiologically
SUMOylated Arc, due to histidine tag residues. The presence of non-modified
Arc protein indicates non-covalent complex formation of Arc with His-SUMO
modified proteins or free SUMO. (B) Arc was immunoprecipitated from
HT-1080 cells expressing non-tagged Arc protein and in vitro SUMOylation
was performed with SUMO activating (E1) and conjugating (E2) enzymes in
the presence or absence of SUMO1. Upon addition of SUMO1, an Arc
immunoreactive band at 65 kDa was detected, corresponding to single
SUMO1ylation of Arc. Equal amounts of protein were loaded. No bands were
observed in the gel above the 100 kDa marker.
SUMOylation of Endogenous Arc Following
LTP Induction in the Dentate Gyrus In Vivo
SUMOylation of ectopically expressed Arc may be
unphysiological, as shown for many in vitro SUMO substrates
(Tatham et al., 2009). We used coimmunoprecipitation to assess
SUMOylation of endogenous Arc under basal (non-stimulated)
conditions and after induction of LTP in the dentate gyrus of
FIGURE 2 | SUMO1ylation of endogenous Arc following in vivo
long-term potentiation (LTP) induction. (A) Time course plots of medial
perforant path-dentate gyrus evoked field excitatory postsynaptic potential
(fEPSP) recorded before and after high-frequency stimulation (HFS; indicated
by arrows). Values are mean ± SEM of the maximum fEPSP slope expressed
in percent of baseline. Test pulses were applied at a 0.033 Hz. HFS
(3 × 400 Hz bursts) as indicated by the arrows. Rats were killed at 1 h and 3 h
post-HFS (stippled line) and dentate gyrus was microdissected for
biochemical analysis. (B–F) Coimmunoprecipitation analysis of dentate gyrus
extracts. Bar graphs (left panels) based on densitometric analysis of indicated
bands expressed as fold change in the ipsilateral HFS-treated dentate gyrus
relative to the contralateral, non-stimulated side. Right panels show
representative immunoblots from LTP experiments and naïve dentate gyrus.
IgG lane is IgG-coupled beads plus lysate from HFS-treated dentate gyrus.
(B) SUMO1 immunoprecipitation (rabbit polyclonal) followed by
immunoblotting with Arc C7 antibody. Quantification of upper band
(SUMOylated Arc).
(Continued)
Frontiers in Synaptic Neuroscience | www.frontiersin.org 5 May 2017 | Volume 9 | Article 8
Nair et al. Arc SUMOylation in LTP In Vivo
FIGURE 2 | Continued
(C) Arc immunoprecipitation followed by SUMO1 immunoblot. Quantification
of upper band (SUMO-Arc). The band at 50 kDa is non-specific (IgG).
(D) SUMO2/3 immunoprecipitation followed by Arc immunoblot. (E) Arc
immunoprecipitation (H300) followed by Arc (C7) immunoblot. Fold change in
Arc SUMOylated state based on upper/lower Arc band intensity. (F) Arc
immunoblot in dentate gyrus lysate input samples. β-Actin was used as a
loading control. n = 4/5; Student’s t-test, ∗P < 0.05.
anesthestized rats. Stable field excitatory postsynaptic potential
(fEPSP) LTP was induced by brief bursts of high-frequency
stimulation (HFS) applied to the medial perforant path input
to the dentate gyrus of one hemisphere, while the contralateral
dentate gyrus served as a non-stimulated, internal control
(Figure 2A). Immunoprecipitation using a SUMO1-specific
antibody followed by Arc immunoblotting demonstrated
a high molecular weight band at 65 kDa corresponding to
single, SUMO1-ylated Arc (Figure 2B), as seen in the in vitro
SUMOylation assay (Figure 2B; Supplementary Figure S1A).
Conversely, a 65 kDa SUMO1-immunoreactive band was
detected following immunoprecipitation of Arc (Figure 2C,
Supplementary Figure S1B). Levels of SUMOylated Arc (upper
band quantification) were low in non-stimulated dentate gyrus
from the contralateral hemisphere or naïve anesthetized
rats, and increased 2–3 fold post-HFS (Figure 2B). No
heavy Arc immunoreactive band was detected following
SUMO2/3 immunprecipitation (Figure 2D), indicating
that endogenous Arc is selectively modified by SUMO1.
Unmodified 50 kDa Arc was prominent in both the SUMO1 and
SUMO2/3 pellet from HFS-treated tissue but not in lysates
incubated in control IgG-coated beads (Figures 2B,D),
indicating non-covalent interaction of Arc with SUMOylated
proteins.
SUMOylation could be mediated by constitutive activity of
the SUMOylation machinery, or enhanced activity resulting in
a higher proportion of SUMOylated to unmodified Arc protein
(enhanced SUMOylation state). To estimate changes in Arc
SUMOylation state in LTP, we immunoprecipitated Arc and
measured the ratio of upper band (SUMO-Arc) to lower band
intensity in the Arc immunoblot (Figure 2E). Arc SUMOylation
was significantly enhanced in the HFS treated dentate gyrus
relative to control at 1 and 3 h post-HFS.
SUMO modifications are typically unstable due to
activity of SUMO-specific proteases (SENPs). Detection of
SUMOylated proteins often requires the addition of the
cysteine (and SUMO) protease inhibitor NEM to the lysis.
The biochemical experiments in Figure 2 were all performed
with NEM added to the lysis and immunoprecipitation
buffers. To further validate Arc SUMOylation, assays were
performed with and without NEM in the buffers. In the
Arc immunoprecipitation analysis shown in Figure 3A, HFS
induced a significant 2.2-fold increase in Arc SUMOylation
(ratio of upper to lower Arc immunoreactive band) in
NEM-treated samples, whereas no change in SUMO-Arc
was detected in the absence of NEM (Figures 3A–C). In the
SUMO1 precipitate, 65 kDa SUMO-Arc and unmodified
Arc were only reliably detected in NEM-treated samples
(Figure 3B). The NEM-sensitivity of unmodifed Arc again
suggests extensive non-covalent interaction of Arc with
proteins that were precipitated by anti-SUMO1 antibody. As
an additional validation, we performed a SENP1 enzymatic
digestion of Arc immunoprecipitates. SENP1 treatment
abolished the 65 kDa SUMO-Arc immunoreactive band
present in control samples (Figure 3D). Thus, the
coimmunoprecipitation analysis combined with the effects
of NEM and SENP1 treatment support in vivo SUMOylation of
Arc protein in LTP.
Newly Synthesized, BDNF-Induced Arc Is
SUMOylated during LTP Consolidation
In Vivo
LTP consolidation requires a period of sustained Arc
synthesis mediated by persistent BDNF-TrkB activation of
Arc translation (Messaoudi et al., 2007; Panja et al., 2009,
2014; Panja and Bramham, 2014). Acute inhibition of Arc
translation with antisense RNA or local infusion of the
BDNF-scavenger TrkB-Fc results in rapid (minutes) loss
of Arc protein and inhibition of LTP maintenance. This
suggested that Arc protein involved in LTP is synthesized
and degraded in rapid cycles. We therefore considered that
Arc SUMOylation could occur on: (1) newly synthesized,
labile Arc protein involved in LTP maintenance; (2) newly
synthesized, stable Arc protein; or (3) pre-existing Arc
protein.
Two hours after HFS, rats received a unilateral infusion
(1 µl, 12.5 min) of TrkB-Fc or control human IgG into the
dorsal hippocampus, and dentate gyrus tissue was collected
at 4 h post-HFS. As expected, TrkB-Fc infusion resulted
in complete reversion of LTP (Figure 4A) and inhibition
of Arc expression relative to the IgG-Fc infused control.
Coimmuno-precipitation analysis further showed reduction
of SUMO1-ylated Arc to controls levels following TrkB-Fc
treatment (Figure 4B). Arc SUMOylation state was again
estimated by the ratio of upper to lower band intensity in
the Arc immunoprecipitate (Figure 4B). A significant 2.1-fold
increase in Arc SUMOylation state was abolished by TrkB-Fc
treatment (Figure 4C). We conclude that newly synthesized,
BDNF-induced Arc is dynamically SUMOylated in the context
of LTP consolidation.
Enhanced Arc SUMOylation in the
Synaptoneurosome Compartment
Arc protein exhibits a widespread somatodendritic pattern of
expression in dentate granule cells following LTP-induction
(Messaoudi et al., 2007; Steward et al., 2015). Arc protein
expression is transiently enriched in dendritic spines of medial
perforant path synapses (Moga et al., 2004; Rodríguez et al.,
2005; Farris et al., 2014; Steward et al., 2015). Functionally, Arc
is critical for stable F-actin increases (Messaoudi et al., 2007),
and F-actin expansion is essential for long-term enlargement
of dendritic spines (Fukazawa et al., 2003; Bramham, 2008;
Tanaka et al., 2008; Bosch et al., 2014; Bailey et al.,
2015). Arc also accumulates in neuronal nuclei, where it
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FIGURE 3 | N-ethylmaleimide (NEM) dependent retention of SUMO-modified Arc. Coimmunoprecipitation was carried with and without the addition of the
cysteine (SUMO) protease inhibitor NEM to the lysis and immunoprecipitation buffer. (A) Detection of enhanced Arc SUMOylation during LTP is NEM-dependent. The
ratio of upper to lower Arc immunoreacitive bands was determined in Arc immunoprecipitates. Bar graphs show fold change in HFS-treated dentate gyrus compared
to control. n = 5; Student’s t-test, ∗P < 0.05. (B) Immunoprecipitation of Arc, SUMO1 and SUMO2/3 was performed in the presence or absence of NEM and
precipitates were immunoblotted for Arc. Representative blot from a single gel. A 65 kDa immunoreactive Arc band (arrow) was reliably detected only in
NEM-processed samples. The non-covalent interaction of Arc with SUMO1 and SUMO2/3 was also NEM-dependent. (C) Arc immunoblots of dentate gyrus lysate
(input) samples. NEM treatment tended to increase Arc immunoreactivity but there was no difference in fold increases in Arc with and without NEM (n = 5, P > 0.05).
(D) SENP1 enzymatic treatment of Arc immunoprecipitate abolished 65 kDa SUMO-Arc. In this immuno-precipitation performed with a polyclonal antibody from
Synaptic Systems, an additional 75 kDa Arc immunoreactive band was detected by the monoclonal mouse Arc C7 antibody. However, the 75 kDa band could not be
validated in the reverse immunoprecipitation or by SUMO1 immunoprecipitation.
may function in homeostatic plasticity (Korb et al., 2013).
If SUMOylated Arc functions in dendritic spines during
LTP, it should be present in the glutamatergic synaptic
compartment.
To address this question, we examined Arc SUMOylation
in fractionated dentate gyrus synaptoneurosomes collected 1,
3 and 4 h after LTP induction. Synaptoneurosomes are highly
enriched in pinched-off dendritic spines and well-suited for
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FIGURE 4 | Newly synthesized brain-derived neurotrophic factor
(BDNF)-induced Arc is SUMOylated during LTP consolidation. (A) Time
course plots of medial perforant path-dentate gyrus evoked fEPSPs recorded
before and after HFS (indicated by arrows). Values are mean ± SEM of the
maximum fEPSP slope expressed as percent of baseline. TrkB-Fc or control
IgG-Fc (1 µl, 12.5 min, 100 µg) was infused into the dorsal dentate gyrus at
2 h post-HFS (indicated by a bar) and dentate gyrus tissue was collected at
4 h post-HFS (stippled line). TrkB-Fc infusion reverted ongoing LTP
maintenance. (B) Bi-directional coimmunoprecipitation of SUMOylated Arc
using anti-SUMO1 and anti-Arc antibodies. Enhanced Arc expression and Arc
SUMO1ylation in HFS-treated dentate gyrus was reverted to baseline levels by
TrkB-Fc infusion. (C) Bar graph shows fold change in Arc SUMOylation state
in HFS-treated dentate gyrus compared to contralateral control in TrkB-Fc and
IgG-Fc infused rats. Arc immunoprecipitation was performed and the ratio of
65 kDa (SUMO-Arc) to unmodified 50 kDa Arc was calculated. n = 5;
Student’s t-test, ∗P < 0.05.
capturing signaling events in the postsynaptic compartment
(Håvik et al., 2003; Kanhema et al., 2006; Panja et al., 2014). Arc
protein was enriched in synaptoneurosomes relative to whole
dentate lysates in control and HFS-treated dentate gyrus. In
non-stimulated dentate gyrus, a 65 kDa Arc-immunoreactive
band was detected in synaptoneurosomes but not whole
lysate samples (Figure 5A). The heavy 65 kD Arc band was
clearly detected in both lysates synaptoneurosomes following
HFS-induced upregulation of Arc. Based on the ratio of
the upper to lower Arc band intensity, synaptoneurosomes
exhibited a significant ∼2-fold increase in Arc SUMOylation
at 1 and 3 h post HFS (Figure 5B). Immunoprecipitation with
anti-SUMO1 antibody performed in synaptoneurosomes
from naive dentate gyrus confirmed the 65 kDa band
as SUMO1-ylated Arc (Figure 5C). As in whole lysates
samples, a single prominent high molecular weight Arc
species is observed in the SUMO1 preciptate. Non-covalent
coupling to SUMO1ylated proteins is also clearly present
in the synaptoneurosomal fraction (Figure 5C). Finally,
SENP1 treatment removed the SUMO1-Arc band detected
FIGURE 5 | Enhanced Arc SUMOylation in the synaptoneurosome
compartment during LTP in vivo. (A) Representative Arc immunoblot
performed in dentate gyrus whole lysate and fractionated synaptoneurosome
samples. (B) Fold change in SUMOylated Arc based on the ratio of the upper
and lower Arc immunoreactive bands. Two dentate gyri were pooled each
experiment. n = 4; Student’s t-test, ∗P < 0.05. (C) SUMO1immuno-
precipitation (mouse monoclonal) followed by Arc immunoblotting confirmed
Arc SUMOylation in synaptoneurosomes. Unmodified Arc is also detected in
the SUMO1 pellet. (D) SENP1 digestion removed SUMOylated Arc. The heavy
band detected in the Arc and SUMO1 immunoprecipitate is absent in SENP1
treated samples. Arc was immunoprecipitated with mouse monoclonal Arc C7
antibody. #The polyclonal rabbit Arc antibody (Synaptic Systems) used for
immunoblotting detects a spurious band in the lysate that is absent in the Arc
pellet. ∗Bands due to SENP1 enzyme in the blot; right lane shows SENP1
enzyme loaded alone. 6% polyacrylamide gel.
by Arc and SUMO1 immunoprecipitation (Figure 5D). Thus,
SUMOylated Arc is enriched in the synaptic compartment under
basal conditions and undergoes enhanced expression following
LTP induction.
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Enhanced Arc SUMOylation in the Dentate
Gyrus Cytoskeletal Fraction
Next we used subcellular fractionation to further identify
the subcompartments of for Arc SUMOylation and non-
covalent interactions. Five fractions (cytosol, membrane, soluble
nuclear, chromatin bound nuclear and cytoskeletal) from
dentate gyrus were characterized by immunoblotting using
compartment-enriched marker proteins (Figure 6A). Arc
immunoblotting revealed expression of the SUMOylated and
unmodified Arc in the cytoskeletal fraction of HFS-treated
FIGURE 6 | Enhanced Arc SUMOylation in the cytoskeletal fraction
during LTP in vivo. (A) Immunoblot characterization of dentate gyrus
subcellular fractions. Ipsilateral HFS-treated (Ipsi), contralateral control
(Contra), and Naïve. Vimentin and histone 1 were used as markers of the
cytoskeletal and nuclear fractions, respectively. Tissue was collected 1 h
post-HFS and fractions collected from four dentate gyri were pooled. A
65 kDa Arc immunoreactive band (indicated by an arrow) was detected in the
cytoskeletal fraction. (B) Bidirectional co-immunoprecipitation using
anti-SUMO1 and anti-Arc antibodies was performed in dentate gyrus
cytoskeletal fractions. SUMO1ylated Arc was detected at 65 kDa.
Representative blots based on three independent biological replicates.
Sameples from two dentate gyrus were pooled. Note the absence of
unmodified Arc in the SUMO1 pellet. (C) Arc immunoprecipitation was
performed in the cytoskeletal fraction from HFS-treated and control dentate
gyrus. (D) Arc immunoblot analysis of cytoskeletal fraction. Bar graphs shows
increase in Arc expression and enhanced Arc SUMOylation based on the ratio
of upper/lower Arc bands in the dentate gyrus cytoskeletal fraction at 1 h
post-HFS relative to contralateral control. n = 5; Student’s t-test, ∗P < 0.05.
Representative Arc immunoblots on right. Arrow indicates 65 kDa
SUMOylated Arc.
and non-stimulated dentate gyrus (Figure 6A). Following LTP
induction, 50 kDa Arc was prominently upregulated in all
subcellular fractions (Figure 6A). However, SUMOylated
Arc could only be detected in the cytoskeletal fraction.
Bi-directional coimmunoprecipitation analysis of pooled
denate gyrus cytoskeletal fractions confirmed the 65 kDa
band as SUMO1ylated Arc (Figure 6B), and its enhanced
expression in HFS-treated dentate gyrus (Figure 6C). In
contrast to synaptoneurosomes, non-covalent interaction
of Arc with SUMO precipitated proteins was absent in the
cytoskeletal fraction (Figure 6C). A quantitative analysis of Arc
SUMOylation in the cytoskeletal fraction was by done by Arc
immunoblot analysis. As shown in Figure 6D, Arc SUMOylation
was significantly enhanced 2.1–fold in the cytoskeletal fraction
of HFS-treated dentate gyrus relative to control.
SUMO1-ylated Arc Interacts with the
F-Actin-Binding Protein Drebrin A
Biochemically, Arc is flexible and has numerous binding partners
indicating a hub-like function of the protein (Myrum et al.,
2015). A major outstanding question is whether Arc protein
engages functionally distinct protein partners following LTP-
induction. If so, Arc SUMOylation might serve to direct
the formation of specific protein-protein interactions within
neuronal subcompartments. As SUMOylation was enriched at
synapses and not detected in the nuclear fractions, we focused
on a set of known Arc interaction partners (CaMKIIα, CaMKIIβ,
dynamin 2 and PSD-95) found in postsynaptic dendrites and
spines. Arc binding to CaMKIIβ recruits Arc for inverse synaptic
tagging (Okuno et al., 2012), binding to dynamin 2 promotes
AMPA receptor endocytosis (Chowdhury et al., 2006; Shepherd
et al., 2006), while binding to PSD-95 curtails TrkB-coupled
phospholipase C signaling (Husi et al., 2000; Cao et al., 2013). Arc
immunoprecipitation followed by immunoblotting confirmed
interaction with all binding partners in dentate gyrus lysates
and suggest an enhanced interaction of Arc with CaMKIIα,
CaMKIIβ and dynamin 2 after LTP induction (Supplementary
Figures S2A–C). Next, the respective binding partners were
immunoprecipitated fromHFS-treated dentate gyrus and probed
for Arc. The protein interaction complexes formed by CaMKIIα,
CaMKIIβ, PSD-95 and dynamin 2 all contained non-modified
Arc, but none of these complexes contained detectable levels
65 kDa SUMOylated Arc (Supplementary Figures S2D–F).
Arc cosediments with a crude F-actin but not with more
purified actin preparations suggesting an indirect association of
Arc with actin filaments (Lyford et al., 1995). We hypothesized
that SUMOylation might target Arc to an F-actin binding
protein involved in actin cytoskeletal remodeling in LTP.
Coimmunoprecipitation assays were performed with drebrin A
and cofilin 1. These actin side-binding proteins are important
for the structural and functional plasticity of dendritic spines
(Fukazawa et al., 2003; Meng et al., 2005; Messaoudi et al.,
2007; Flynn et al., 2012; Bosch et al., 2014; Kojima et al.,
2016). Arc and drebrin A were reliably co-precipitated using
anti-Arc or anti-drebrin A antibodies for affinity purification
(Figures 7A,B), and SUMOylated Arc was clearly detected in the
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FIGURE 7 | Enhanced Arc SUMOylation and selective interaction with
F-actin-binding protein drebrin A during LTP in vivo. (A) Arc was
detected in complex with drebrin A immunoprecipitated from the dentate
gyrus lysates following LTP induction 10% polyacrylamide gel. (B) Drebrin A,
but not cofilin, was detected in the Arc immunoprecipitate from the
cytoskeletal fraction. (C) Arc, but not drebrin A, was detected following
immunopreciptation of calcium/calmodulindependent protein kinase II–alpha
(CaMKIIα) and CaMKIIβ. Also see Supplementary Figure 2. (D) Drebrin A was
immunoprecipitated from pooled cytoskeletal fractions and immunoblotted for
Arc. Changes in Arc SUMOylation were quantified as the ratio of the upper to
lower Arc immunoreactive bands. Arc SUMOylation in complex with debrin A
in the cytoskeletal fraction was increased in HFS-treated dentate gyrus relative
to control. n = 4; Student’s t-test, ∗P < 0.05.
drebrin A precipitate (Figure 7A). In contrast, Arc and cofilin
did not coimmunoprecipitate (Figure 7B).
Like drebrin A, CaMKIIα and CaMKIIβ are Arc binding
partners that are enriched in the postsynaptic density and
cytoskeletal fraction. However, these complexes are distinct
as immunoprecipitation of CaMKIIα and CaMKIIβ resulted
in copurification of Arc, but not drebrin A (Figure 7C and
Supplementary Figure S2). Finally, we examined changes in
SUMOylated Arc in complex with cytoskeletal drebrin A during
in vivo LTP. Drebrin A was immunoprecipitated from pooled
dentate gyrus cytoskeletal fractions and probed for SUMOylated
Arc. Arc SUMOylation state was significantly enhanced in the
drebrin A pellet from HFS-treated dentate gyrus relative to
control (Figure 7D). Thus, Arc is SUMOylated during LTP and
associates with the synaptic cytoskeletal fraction and the actin
regulatory protein drebrin A.
DISCUSSION
Arc is an indispensable component of both LTP and
depression of synaptic transmission, but the mechanisms
dictating Arc protein localization and function are not
understood. The present study demonstrates SUMOylation
of newly synthesized Arc during the maintenance phase
of LTP in live anesthetized rats. Arc is conjugated by a
single SUMO1 protein under these in vivo conditions; no
evidence was obtained for polySUMOylation or modification
by SUMO2/3. Following LTP induction, BDNF signaling drives
synthesis of Arc, which undergoes rapid SUMOylation and
association with drebrin A, a regulator of F-actin stability in
dendritic spines. Although Arc also coimmunoprecipitates
with dynamin 2, CaMKIIβ and PSD-95, these complexes
do not contain SUMOylated Arc. Previous work showed
that Arc is required for stabilization of F-actin during LTP
in the dentate gyrus. The presents work shows that Arc
interacts with functionally diverse protein partners following its
induction by high-frequency synaptic activation, and specifically
links SUMO-Arc to an actin cytoskeletal function of the
protein.
Non-modified Arc was massively increased in the nuclear,
cytosolic and membrane fractions following LTP induction,
but these fractions lacked SUMOylated Arc. Only the
synaptoneurosomal and cytoskeletal fractions expressed
non-modified and SUMOylated Arc in the basal state and
enhanced expression of both following LTP induction. Previous
work showed that Arc protein is persistently synthesized
and rapidly degraded in LTP consolidation, indicating a
critical role for fast-acting Arc protein (Messaoudi et al.,
2007; Panja et al., 2009, 2014). Here we found that newly
synthesized Arc is rapidly SUMOylated and degraded during
LTP.
In vivo Arc SUMOylation is shown by
coimmunoprecipitation analysis and the sensitivity of
SUMO1-Arc to NEM and SENP1 treatment. Changes in
SUMOylation state were assessed as the ratio between
65 kDa (SUMO1ylated Arc) to unmodified Arc in the
Arc immunoprecipitate. In dentate gyrus lysate samples,
synaptoneurosomes, the cytoskeletal fraction, and drebrin A
immunoprecipitate, significantly enhanced Arc SUMOylation
was found during the LTP maintenance phase. Local inhibition
of TrkB signaling reverted Arc synthesis and enhanced
SUMOylation, demonstrating dynamic SUMOylation of newly
synthesized Arc. Further studies employing SUMO1-Arc
specific antibodies or mass spectroscopy are need to
definitively quantify changes in Arc SUMOylation state.
Recent works suggests that postsynaptic SUMOylation is
at least in part regulated by activity-dependent diffusion
and transient synaptic trapping of the SUMO conjugating
enzyme, Ubc9 (Loriol et al., 2013; Schorova and Martin,
2016).
In the process of inverse synaptic tagging, Arc localizes
to less active synapses by binding to inactive CaMKIIβ
and further promotes the selective weakening of these
synapses by association with dynamin 2 and facilitation
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of AMPA receptor endocytosis (Okuno et al., 2012). The
interaction of Arc with CaMKIIβ and dynamin 2 following
LTP induction supports the view that inverse tagging and
LTP consolidation are concurrent processes. Although drebrin
A, CaMKIIα, CaMKIIβ, PSD-95 are all highly enriched in
the postsynaptic compartment and cytoskeletal fraction,
SUMO1-Arc was detected only in complex with drebrin A.
Taken together this suggests that SUMOylation targets newly
synthesized Arc for regulation of actin cytoskeletal dynamics
in LTP.
Drebrin A is known to stabilize the suprastructure of the
actin cytoskeleton by bundling F-actin or linking F-actin to
the PSD (Hayashi et al., 1996; Ivanov et al., 2009; Sharma
et al., 2011; Ferhat, 2012; Mikati et al., 2013). Following
dentate gyrus LTP in awake rats, the F-actin content and
intensity of drebrin A immunoreactivity are stably enhanced
at medial perforant path synapses (Fukazawa et al., 2003).
In adult drebrin A knockout mice, LTP in the hippocampal
CA1 region and contextual fear memory are impaired (Kojima
et al., 2016). Studies of chemically-induced LTP in cultured
neurons support a two-stage model in which the exodus of
short, drebrin A-decorated actin filaments from the spine
head into dendritic shaft allows initial expansion of the
F-actin network in spines, while reentry of drebrin stabilizes
nascent filaments and supports long-term spine enlargement
(Sekino et al., 2006; Mizui et al., 2014). Taken together
current evidence implicates drebrin A in the fast transition
between dynamic and stable states of actin in dendritic
spines (Shirao and González-Billault, 2013; Grintsevich and
Reisler, 2014). As a working hypothesis we propose that
SUMOylated Arc contributes to the dynamic phase of drebrin
A incorporation into, and stablization of, nascent actin filaments
during LTP.
SUMOylation reactions are typically transient and involve
only a small fraction of the total substrate pool at steady state
(Tirard et al., 2012; Flotho and Melchior, 2013; Henley et al.,
2014). Consistent with this, we show that only a fraction of
the Arc protein in complex with drebrin A is SUMOylated.
The presence of drebrin/SUMO-Arc complexes in the basal
state (contralateral and naïve dentate gyrus) may represent a
subpopulation of synapses undergoing long-term modification,
in-line with the small subpopulations of granule cells expressing
Arc mRNA in behaving animals.
Cofilin and drebrin A are both side-binding regulators of
actin filaments. Cofilin severs actin filaments and promotes
turnover whereas drebrin A stabilizes filaments. During
LTP consolidation, Arc synthesis is required to maintain
cofilin in a phosphorylated, inhibited state (Messaoudi
et al., 2007). The observed lack of coimmunoprecipitation
between Arc and cofilin in the present study indicates that
Arc’s impact on cofilin activity is indirect. As cofilin and
drebrin are known to compete for binding to filaments
(Zhao et al., 2006; Grintsevich and Reisler, 2014), it
is possible that Arc impacts cofilin phosphorylation
indirectly by modulating drebrin A activity. The reciprocal
coimmunoprecipitation between Arc and drebrin A indicates
a close interaction in a common complex, but not necessarily
direct binding. Arc interaction with drebrin A may require other
factors.
Arc has predicted consensus SUMOylation sites at lysine
110 and lysine 286 (Bramham et al., 2010), and mutation
of these sites blocks in vitro Arc SUMOylation in HEK cells
(Craig et al., 2012). In cultured hippocampal neurons, viral
overexpression of the Arc-KK SUMO mutant, but not wild-type
Arc, prevents tetrodotoxin-induced synaptic scaling, indicating
that Arc SUMOylation may be required for homeostatic scaling
of AMPARs (Craig et al., 2012). Overexpression of Arc-KK does
not affect GluA1 endocytosis, suggesting that Arc SUMOylation
promotes the forward trafficking of GluA1 to the cell surface
and thus favors homeostatic potentiation of synapses during
chronic acitivity blockade (Craig and Henley, 2012; Craig et al.,
2012). It is further noteworthy that drebrin A, which we have
shown interacts with SUMOylated Arc, is implicated in the
activity-dependent membrane insertion of AMPARs (Kato et al.,
2012).
Although in vitro evidence implicates consensus lysine
residues, the site(s) of SUMO conjugation on endogenous Arc
have not been defined. SUMOylation commonly occurs on
non-consensus lysines, whereas predicted consensus lysines are
often not SUMOylated (Flotho andMelchior, 2013; Henley et al.,
2014). In the study of Craig et al. (2012), 75 kDa and 120 kDa
SUMO-reactive bands were immunoprecipitated from rat brain
lysate using anti-Arc antibody, consistent with double and
polySUMOylation. Using SUMO1 immunoprecipitation
from rat dentate gyrus lysates, synaptoneurosomes and
cytoskeletal fractions, we deteted a single high molecular
weight Arc-immunoreactive species at 65 kDa, indicating
single SUMO1 modification of Arc, as also seen by in vitro
SUMOylation of immunoprecipitated Arc.
Arc is known to be ubiquitinated on lysine 268 and
269 by the E3 ligases Triad3A and Ube3a and targeted for
proteasomal degradation (Rao et al., 2006; Greer et al., 2010;
Soulé et al., 2012; Kühnle et al., 2013; Mabb et al., 2014).
If SUMO and ubiquitin compete for modification of lysine
residues on Arc, SUMOylation would be predicted to slow
Arc degradation. However, Arc wildtype and Arc KK mutant
have similar degradation rates when overexpressed in cultured
hippocampal neurons (Craig et al., 2012), and likewise we saw
rapid degradation of endogenous and SUMOylated Arc in the
context of LTP.
Another salient finding of the present study was the
presence of non-modified 50 kDa Arc in the SUMO1 and
SUMO2/3 precipitate, demonstrating non-covalent
interaction of Arc with SUMOylated proteins or with
free SUMO. SUMO-interacting motifs (SIMs) typically
consist of a hydrophobic core flanked by acidic residues (or
phosphorylatable serine residues; Gareau and Lima, 2010). A
major role of SIMs is to allow formation of specific SUMO-based
interaction complexes, and many neuronal and synaptic proteins
appear to contain SIMs (Feligioni et al., 2009; Wilkinson
et al., 2010). Sequence alignment of Arc with known SIMs
(RanBP2, Human PML and Daxx; Song et al., 2004; Lin et al.,
2006) predicts a SIM-like motif (317EEEEIIQYVV) in the Arc
C-terminal domain. However, it remains to be seen whether
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Arc binds SUMO directly. Recovery of unmodified Arc in the
SUMO pellet was highly NEM-dependent, indicating that Arc
interacts with SUMOylated proteins rather than to free SUMO.
This interaction was detected in lysates and synaptoneurosomes
but not in the cytoskeletal fraction, suggesting that non-covalent
interaction of Arc with SUMOylated proteins occurs in the spine
compartment but not in association with the actin cytoskeleton.
SUMOylation has recently been shown to inhibit or promote
specific protein aggregation in neurons. The translational
repressor, cytoplasmic polyadenylation binding protein
(CPEB3), undergoes activity-dependent deSUMOylation
resulting in aggregation of CPEB3 and enhanced translation
(Drisaldi et al., 2015). In contrast, aggregation of α-synuclein
in dopaminergic neurons of the substantia nigra is inhibited by
SUMOylation (Krumova et al., 2011). Recent work showed
that recombinant human Arc exists as a monomer but
is capable of reversible self-oligomerization (Byers et al.,
2015; Myrum et al., 2015). It will therefore be important
to determine if SUMOylation impacts the oligomeric state
of Arc.
Arc can be thought of as a flexible hub protein and organizer
of neuronal plasticity through interaction with multiple protein
partners in different subcellular compartments. The present
works strongly implicates SUMOylation in the regulation of
Arc localization and function in synaptic plasticity in vivo.
Further work is needed to identify SUMO-directed protein-
protien interactions and causal roles of Arc SUMOylation.
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